methyl 5-aminolevulinate has been researched along with Carcinogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bay, C; Haedersdal, M; Karmisholt, KE; Phothong, W; Togsverd-Bo, K; Wenande, E | 1 |
| Mühlstädt, M | 1 |
2 other study(ies) available for methyl 5-aminolevulinate and Carcinogenesis
| Article | Year |
|---|---|
Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side-by-side, single-blind trial in patients with actinic keratosis and large-area field cancerization.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinogenesis; Combined Modality Therapy; Dermabrasion; Dose Fractionation, Radiation; Female; Humans; Keratosis, Actinic; Laser Therapy; Light; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Single-Blind Method; Skin; Treatment Outcome | 2019 |
Ingenol Mebutate vs. Daylight Photodynamic Therapy in a Kidney Transplant Recipient.
Topics: Aged; Aminolevulinic Acid; Antineoplastic Agents; Carcinogenesis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Face; Humans; Keratosis, Actinic; Kidney Transplantation; Male; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Transplant Recipients | 2016 |